Insight Molecular Diagnostics (IMDX) Inventory Average (2024 - 2026)

Insight Molecular Diagnostics has disclosed Inventory Average across 3 years of filings, most recently posting $414000.0 for Q1 2026.

• Inventory Average for Q1 2026 came in at $414000.0, down 4.72% year-over-year; the trailing twelve-month figure through Mar 2026 was $414000.0 (down 4.72% YoY), and the FY2025 annual result was $428000.0, changed N/A from the prior year.
• Inventory Average came in at $414000.0 for Q1 2026 at Insight Molecular Diagnostics, down from $458500.0 in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $582000.0 in Q3 2025 to a low of $321000.0 in Q4 2024.
• The 3-year median for Inventory Average is $446500.0 (2025), against an average of $464333.3.
• Across the five-year window, Inventory Average jumped 42.83% in 2025 and slipped 4.72% in 2026, its largest moves.
• Insight Molecular Diagnostics' Inventory Average stood at $321000.0 in 2024, then jumped by 42.83% to $458500.0 in 2025, then slipped by 9.71% to $414000.0 in 2026.
• The last three Inventory Average figures came in at $414000.0 (Q1 2026), $458500.0 (Q4 2025), and $582000.0 (Q3 2025), per Business Quant data.